Comment on: ‘Systemic prostacyclin analogues in pulmonary hypertension are associated with reduced risk of age-related macular degeneration: a cohort study’

Weiwei She, Mingde She, Tianshou Sun

Open source

DOI
10.1038/s41433-026-04378-4
Published
2026-07-31
Container
Eye
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41433-026-04378-4,
  title = {Comment on: ‘Systemic prostacyclin analogues in pulmonary hypertension are associated with reduced risk of age-related macular degeneration: a cohort study’},
  author = {Weiwei She and Mingde She and Tianshou Sun},
  year = {2026},
  journal = {Eye},
  doi = {10.1038/s41433-026-04378-4},
  url = {https://doi.org/10.1038/s41433-026-04378-4}
}

RIS

TY  - JOUR
TI  - Comment on: ‘Systemic prostacyclin analogues in pulmonary hypertension are associated with reduced risk of age-related macular degeneration: a cohort study’
AU  - Weiwei She
AU  - Mingde She
AU  - Tianshou Sun
PY  - 2026
JO  - Eye
DO  - 10.1038/s41433-026-04378-4
UR  - https://doi.org/10.1038/s41433-026-04378-4
ER  - 

APA

She, W., She, M., & Sun, T. (2026). Comment on: ‘Systemic prostacyclin analogues in pulmonary hypertension are associated with reduced risk of age-related macular degeneration: a cohort study’. Eye. https://doi.org/10.1038/s41433-026-04378-4

Source records